Seattle, WA (PRWEB) April 08, 2014
Quorum Review IRB, the industry leader in central IRB services, announces today their Regulatory Attorney, Mitchell E. Parrish, JD, RAC, CIP, as a presenter at AAHRPP’s 2014 Conference. The event takes place April 23-25, 2014 at the Marriott Hotel in downtown Salt Lake City, Utah.
Mr. Parrish’s presentation, “Reviewing Research Involving Medical Devices,” is held at 1:15 PM on Thursday, April 24, 2014. The discussion will focus on ethics review for medical device research. Of the topic, Mr. Parrish says, “I am eager to present on the topic of medical devices. This area of clinical research has unique regulatory challenges, and I hope to share some useful insights from the IRB perspective.”
Mr. Parrish is a Regulatory Attorney for Quorum Review, where he provides legal counsel on regulatory issues and FDA requirements associated with research and development of medical products. Mr. Parrish is a member of the Regulatory Affairs Professionals Society, Public Responsibility in Medicine & Research, American Association of Corporate Counsel, and Washington State Bar Association. He is also a Certified IRB Professional (CIP) and guest lectures for the Masters of Science Program in Biomedical Regulatory Affairs at the University of Washington. Prior to Quorum, Mr. Parrish served as Regulatory Counsel for Western IRB and as a Regulatory Consultant for the National Cancer Institute.
AAHRPP, the Association for the Accreditation of Human Research Protection Programs, Inc., is a Washington, D.C.-based non-profit accrediting body that uses a voluntary, peer-driven, educational model to ensure that human research subject programs meet rigorous standards for quality and protection. Their annual conference draws legal experts and medical professionals from across the clinical and academic research spectrums.
More information on Quorum’s ethics review services can be found at http://www.quorumreview.com.
About Quorum Review
Quorum Review is an independent ethics review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH) and principles of the Belmont Report.
Quorum’s best-in-class service and support includes 15 Board meetings each week, plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and SmartForms for online submissions. Quorum’s service offerings include full study review in the US, as well as internationally; a specialized Phase I team; institution-specific support; and efficient processes for minimal risk studies.